N-(2,6-Dimethylphenyl)-2-({3-methyl-4-oxo-7-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}sulfanyl)acetamide

Catalog No. :
ACDVTB805
CAS No. :
1040632-43-6
Molecular Formula :
C23H21N3O2S2
Molecular Weight :
435.57

IUPAC Name:N-(2,6-dimethylphenyl)-2-((3-methyl-4-oxo-7-phenyl-3,4-dihydrothieno[3,2-d]pyrimidin-2-yl)thio)acetamide

N-(2,6-Dimethylphenyl)-2-({3-methyl-4-oxo-7-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}sulfanyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2,6-Dimethylphenyl)-2-({3-methyl-4-oxo-7-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}sulfanyl)acetamide
IUPAC NameN-(2,6-dimethylphenyl)-2-((3-methyl-4-oxo-7-phenyl-3,4-dihydrothieno[3,2-d]pyrimidin-2-yl)thio)acetamide
MDL No.MFCD11997061
Molecular FormulaC23H21N3O2S2
Molecular Weight435.57
SMILESO=C(NC1=C(C)C=CC=C1C)CSC2=NC(C(C3=CC=CC=C3)=CS4)=C4C(N2C)=O
InChI KeyRRMHKWCJNUTNSZ-UHFFFAOYSA-N
SynonymN-(2,6-dimethylphenyl)-2-({3-methyl-4-oxo-7-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}sulfanyl)acetamide;Acetamide, 2-[(3,4-dihydro-3-methyl-4-oxo-7-phenylthieno[3,2-d]pyrimidin-2-yl)thio]-N-(2,6-dimethylphenyl)-
CAS No.1040632-43-6

Synthetic Route by SureRoute

1. ACDVTB805 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEDJQ036 route compound structure diagram
    ACEDJQ0361131-01-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDVTB805 route product structure diagram
    ACDVTB8051040632-43-6
Inquiry

2. ACDVTB805 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXSVE904 route compound structure diagram
    ACXSVE90421436-98-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDVTB805 route product structure diagram
    ACDVTB8051040632-43-6
Inquiry

Comments (0)